CymitQuimica logo

CAS 72803-02-2: Darodipine

Formula:C19H21N3O5
InChI:InChI=1S/C19H21N3O5/c1-5-25-18(23)14-10(3)20-11(4)15(19(24)26-6-2)16(14)12-8-7-9-13-17(12)22-27-21-13/h7-9,16,20H,5-6H2,1-4H3
InChI key:InChIKey=QERUYFVNIOLCHV-UHFFFAOYSA-N
SMILES:C(OCC)(=O)C=1C(C(C(OCC)=O)=C(C)NC1C)C=2C=3C(C=CC2)=NON3
Synonyms:
  • 2,1,3-Benzoxadiazole, 3,5-pyridinedicarboxylic acid deriv.
  • 3,5-Pyridinedicarboxylic acid, 4-(2,1,3-benzoxadiazol-4-yl)-1,4-dihydro-2,6-dimethyl-, 3,5-diethyl ester
  • 3,5-Pyridinedicarboxylic acid, 4-(2,1,3-benzoxadiazol-4-yl)-1,4-dihydro-2,6-dimethyl-, diethyl ester
  • 3,5-Pyridinedicarboxylic acid, 4-(4-benzofurazanyl)-1,4-dihydro-2,6-dimethyl-, diethyl ester
  • Darodipine [USAN:INN]
  • Darodipino
  • Darodipino [Spanish]
  • Darodipinum
  • Darodipinum [Latin]
  • Dazodipin
  • Diethyl 4-(2,1,3-Benzoxadiazol-4-Yl)-2,6-Dimethyl-1,4-Dihydropyridine-3,5-Dicarboxylate
  • See more synonyms
Sort by

Found 4 products.
  • Darodipine

    CAS:
    Darodipine (PY-108068) is a dihydropyridine type Ca+2 antagonist.
    Formula:C19H21N3O5
    Purity:99.25%
    Color and Shape:Solid
    Molecular weight:371.39

    Ref: TM-T15053

    1mg
    60.00€
    2mg
    86.00€
    5mg
    110.00€
    10mg
    155.00€
    25mg
    274.00€
    50mg
    472.00€
    1mL*10mM (DMSO)
    135.00€
  • Darodipine

    CAS:
    Darodipine
    Purity:≥98%
    Molecular weight:371.39g/mol

    Ref: 54-BUP03996

    1mg
    87.00€
    2mg
    118.00€
    5mg
    171.00€
    10mg
    225.00€
    25mg
    390.00€
    50mg
    660.00€
  • Darodipine

    Controlled Product
    CAS:
    Applications Darodipine, is a calcium channel antagonist. References Matucci, R., et al.: British J. Pharmacol., 122, 1353 (1997);
    Formula:C19H21N3O5
    Color and Shape:Neat
    Molecular weight:371.39

    Ref: TR-D193450

    25mg
    347.00€
    250mg
    2,324.00€
  • Darodipine

    CAS:
    Darodipine is a calcium channel blocker, which is derived from dihydropyridine compounds. Its primary mode of action involves the inhibition of voltage-gated calcium channels in the smooth muscle cells of the vascular system. By preventing calcium influx, Darodipine leads to reduced contraction of the vascular smooth muscle, resulting in vasodilation and decreased vascular resistance. The reduced vascular resistance translates into lower blood pressure, making Darodipine valuable in the management of hypertension. Its specificity for vascular smooth muscle over cardiac muscle channels reduces the risk of cardiac side effects commonly associated with non-selective calcium channel blockers. This pharmacological specificity is achieved through its high lipophilicity, which facilitates membrane penetration and selective action at the arterial smooth muscle. Reflecting its potential and targeted effects, Darodipine finds application primarily in clinical settings focused on cardiovascular health, notably in patients diagnosed with hypertension. Its efficacy in reducing arterial pressure, while maintaining a favorable side effect profile, positions it as an effective treatment option for managing chronic hypertension and related cardiovascular conditions.
    Formula:C19H21N3O5
    Purity:Min. 95%
    Molecular weight:371.4 g/mol

    Ref: 3D-XCA80302

    50mg
    1,737.00€
    500mg
    1,976.00€